维普中文期刊产品整合服务
18篇 您的检索式:作者名="Ruottinen HM"
    题名 作者 年代 出处 被引量
1A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease显示文摘Ruottinen HM Rinne UK 1996Clin Neuropharmacol1996,19,:1
2Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: A comparative PET study with raclopride and N-methyl-spiperone显示文摘Kaasinen V Ruottinen HM Nagren K 2000J Nucl Med2000,41,:1
3Rate of progression in Parkinso's disease:a 6-fluoro-L-dopa PET study显示文摘Nurmi E Ruottinen HM Bergman J 2001Mov Disord2001,16,:1
4An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome显示文摘Ruottinen HM Partinen M Hublin C 2000Neurology2000,54,:1
5FDG-PET and Whole-Scalp MEG Localization of Epileptogenic Cortex显示文摘Lamusuo S Forss N Ruottinen HM 1999Epilepsia1999,,7:1
6PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH39166 and carbon-11-NNC 756显示文摘Laihinen AO Rinne JO Ruottinen HM 0,,12:1
7An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome 显示文摘Ruottinen HM Partinen M Hublin C 2000Neurology2000,54,2:1
8An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome显示文摘Ruottinen HM Partinen M Hublin C 2000Neurology2000,54,:1
9Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with raclopride and N-methylspiperone显示文摘 Ruottinen HM Nagren K 2000J Nucl Med2000,41,:1
1018F-FDG PET and whole scalp MEG localization of epileptogenic cortex显示文摘Lumusuo S Forss N Ruottinen HM 1999Epilepsia1999,40,:1
11An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome显示文摘HM Ruottinen Hublin J JO Rinne 2000Neurology2000,54,1:1
12A double-blind pharmacokinetic and clinical doseresponse study of entacapone as an adjunct to levodopa therapy in advaneed Pankinson' s disease显示文摘 Rimme UK 1996Clin Neuropharmacol1996,19,:1
13Progression in Parkinson's disease:a positron emission tomography study with a dopamine transporter ligand CFT 显示文摘 Ruottinen HM Kaasinen V 2000Ann Neurol2000,47,6:1
14A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson' s disease显示文摘Ruottinen HM Rinne UK 1996Clin Neuropharmacol1996,19,:1
15An L - DOPA PET study in patients with periodic limb movement disorder and restless legs syndrome 显示文摘Ruottinen HM Partinen M Hublinc 2000Neurology2000,54,2:1
16Rate of progression in Parkinson's disease: a 6-fluoro-L-dopa PET study显示文摘Nurmi E Ruottinen HM Bergman J 2001Mov Disord2001,16,4:1
17An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome显示文摘Ruottinen HM Partinen M Hublin C 2000Neurology2000,54,:1
18PET and whole-scalp MEG localization of epileptogenic cortex 显示文摘Lamusuo S Forss N Ruottinen HM 1999Epilepsia1999,40,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费